Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mechanoresponsive metabolism in cancer cell migration and metastasis

Cell Metabolism(2021)10.1016/j.cmet.2021.04.002Source: DataRank Database

Mechanoresponsive metabolism in cancer cell migration and metastasis is a research paper published in Cell Metabolism (2021). On theSindex it has a DataRank of 0. It has been cited 356 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access356 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 19.83)OA: bronzeTopics (40)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jian Zhang ORCID,Cynthia A. Reinhart‐King ORCID,Matthew R. Zanotelli ORCID

Live enrichment

PubMed:33915111 PMC:PMC9015673 OpenAlex:https://openalex.org/W3159562858

National Science Foundation Directorate for Education and Human Resources

Grant: DGE-1650411

National Institutes of Health

Grant: GM131178

National Institutes of Health

Grant: HL127499

NIGMS NIH HHS

Grant: R01 GM131178

NHLBI NIH HHS

Grant: R01 HL127499

W. M. Keck Foundation

National Science Foundation

FWCI

19.83

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1550413121001686/pdf

publisherhttp://www.cell.com/article/S1550413121001686/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1550413121001686?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1550413121001686?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cmet.2021.04.002

Fields of Study

Cancer, Hypoxia, and MetabolismCellular Mechanics and InteractionsMicrotubule and mitosis dynamicsAnimalsCell MovementEnergy MetabolismExtracellular MatrixHumansMechanotransduction, CellularNeoplasm MetastasisNeoplasmsTumor Microenvironment

MeSH Terms

AnimalsCell MovementEnergy MetabolismExtracellular MatrixHumansNeoplasm MetastasisNeoplasmsMechanotransduction, CellularTumor Microenvironment

Keywords

Cancer cellExtracellular matrixMetastasisCell biologyBiologyBioenergeticsCell metabolismMotilityCell migrationCancerTumor microenvironmentMetabolismCellNeuroscienceMitochondrionBiochemistryEnergy metabolismMechanotransductionCancer Invasion

Sustainable Development Goals

SDG 0: Affordable and clean energy

Additional file 1 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619173.v1figshare

Additional file 1 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619173figshare

Additional file 2 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619176.v1figshare

Additional file 2 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619176figshare

Additional file 3 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619179figshare

Additional file 3 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619179.v1figshare

Additional file 4 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619182.v1figshare

Additional file 4 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619182figshare

Additional file 5 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619185.v1figshare

Additional file 5 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619185figshare

Additional file 6 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619188.v1figshare

Additional file 6 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

10.6084/m9.figshare.22619188figshare

Additional file 1 of Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis

10.6084/m9.figshare.24355034.v1figshare

Additional file 1 of Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis

10.6084/m9.figshare.24355034figshare

Additional file 1 of Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction

10.6084/m9.figshare.25347050.v1figshare

Additional file 1 of Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction

10.6084/m9.figshare.25347050figshare

Additional file 1 of PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling

10.6084/m9.figshare.26620990.v1figshare

Additional file 2 of PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling

10.6084/m9.figshare.26620993.v1figshare

Additional file 1 of PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling

10.6084/m9.figshare.26620990figshare

Additional file 2 of PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling

10.6084/m9.figshare.26620993figshare